Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.59
+0.16 (2.95%)
Oct 23, 2026, 4:00 PM EDT - Market closed
Cytek Biosciences Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cytek Biosciences stock has a consensus rating of "Buy" and an average price target of $5.56. The average 1-year stock price forecast is 0.54% lower than the current stock price, while the lowest is $4.75 (-15.03%) and the highest is $7.50 (+34.17%).
Price Target: $5.56 (-0.54%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cytek Biosciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens | Stephens | Buy Maintains $4.75 → $6 | Buy | Maintains | $4.75 → $6 | +7.33% | Oct 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $5.5 → $5 | Hold | Maintains | $5.5 → $5 | -10.55% | Oct 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $7.5 | Buy | Reiterates | $7.5 | +34.17% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $5 | Hold | Maintains | $5 | -10.55% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
209.43M
from 201.49M
Increased by 3.94%
Revenue Next Year
223.24M
from 209.43M
Increased by 6.59%
EPS This Year
-0.12
from -0.31
EPS Next Year
0.07
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers.